Glassman Wealth Services Eagle Pharmaceuticals, Inc. Transaction History

Glassman Wealth Services

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$15.21 - $22.88 $790 - $1,189	52 Added 742.86%	59 $0
Q2 2023 Aug 08, 2023	SELL	$17.74 - $31.87 $53 - $95	-3 Reduced 30.0%	7 $0
Q1 2023 May 04, 2023	BUY	$25.06 - $34.09 $250 - $340	10 New	10 $0

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.